An exploratory analysis of bone scan lesion area (BSLA), circulating tumor cell (CTC) change, pain reduction, and overall survival (OS) in patients (pts) with castration-resistant prostate cancer (CRPC) treated with cabozantinib (cabo): Updated results of a phase II nonrandomized expansion (NRE) cohort Meeting Abstract


Authors: Scher, H. I.; Smith, M. R.; Sweeney, C.; Corn, P. G.; Logothetis, C.; Vogelzang, N. J.; Smith, D. C.; Hussain, M.; George, D. J.; De Bono, J. S.; Higano, C. S.; Small, E. J.; Goldin, J.; Brown, M. S.; Aftab, D. T.; Noursalehi, M.; Weitzman, A.; Basch, E. M.
Abstract Title: An exploratory analysis of bone scan lesion area (BSLA), circulating tumor cell (CTC) change, pain reduction, and overall survival (OS) in patients (pts) with castration-resistant prostate cancer (CRPC) treated with cabozantinib (cabo): Updated results of a phase II nonrandomized expansion (NRE) cohort
Meeting Title: 49th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 31
Issue: 15 Suppl.
Meeting Dates: 2013 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2013-05-20
Language: English
ACCESSION: WOS:000335419601626
PROVIDER: wos
Notes: Meeting Abstract: 5026 -- Source: Wos
MSK Authors
  1. Ethan Martin Basch
    150 Basch
  2. Howard Scher
    784 Scher